Please provide your email address to receive an email when new articles are posted on . To compare outcomes between individuals who received outpatient care for COVID-19, compared with those who did ...
COVID-19 is rising in prevalence in many states following the July 4 holiday week, but the role of the main therapy to treat it — the antiviral drug Paxlovid — has become less clear. Research studies ...
A type of respiratory therapy that involves breathing 100% pure oxygen in a hyperbaric chamber improved symptoms of fatigue, brain fog, mood and pain in patients experiencing long COVID-19. The ...
Researchers continue looking at existing medicine for help in the fight against the novel coronavirus, because those drugs already exist and could quickly make a big difference. The latest lead for ...
A study finds that IN-006, a reformulated monoclonal antibody, is safe, well-tolerated, and delivers high antibody levels in the airway—offering a faster and more effective way to fight COVID-19.
Share on Pinterest Some people with long COVID have distortions in their smell of sense for months. F.J. Jimenez/Getty Images Some people with long COVID report lasting alterations to their sense of ...
The Global Plasma Therapy Market has emerged as a crucial segment of the healthcare industry, poised for substantial growth amidst the COVID-19 pandemic. With an estimated CAGR of 15.2% during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results